Israel Tourism Conducts FAM for Indian MICE, Travel and Wedding Companies
by EVENTFAQS Bureau Industry Watch | July 25, 2017 | News
MICE agents from across India recently got to witness Israel’s offerings as a MICE destination on a familiarization (FAM) trip conducted by the Israel Ministry of Tourism (IMOT). The group consisted of agents from leading travel, MICE and wedding companies like Footloose Yatra Consultants, Enchante Holidays, Skyline travels, Travels mantra, Holiday Triangle Travel, Orion Inbound, Tamarind Global, Quantum travels, Byond, Bonton Holidays and WOV travel.
The group got to explore various attractions in cities of Jerusalem, Dead Sea, Eilat and Tel Aviv. The FAM trip provided them the opportunity to see places like Yad Veshem - the World Holocaust Remembrance Center, Israel Museum, Western Wall, Ein Gedi, Masada, Timna Park and also the sound and light show at the Tower of David.
Hassan Madah, Director – IMOT remarked, “Israel is becoming a preferred MICE destination for Indian corporate because of its history, diverse culture, natural beauty, vibrant nightlife and friendly people. Recently, UTI Mutual Funds travelled to Israel with 380 people and explored the cities of Jerusalem, Tel Aviv and Dead Sea. In the last two years, we have seen many such movements and through our FAM trips we hope MICE agents will promote Israel further.”
On Israel as a MICE destination, Neelu Samant, Director, Quantum Travels said, “India’s rapidly evolving MICE consumer is always looking for fresh destinations and Israel holds great promise with fantastic infrastructure, conference facilities in Tel Aviv, Jerusalem and even in Eilat (Red Sea resort town) and Beresheet – which is in the middle of a desert. For a country that is so small in distance, the experiences are plenty for delegates, participants and invitees to any event held in Israel.”
The group consisted of agents from leading travel, MICE and wedding companies, who got to explore various attractions in cities of Jerusalem, Dead Sea, Eilat and Tel Aviv.